What Do Space and Archaeology Have in Common?

On the Space to Grow podcast, Astroscale’s Chris Blackerby and Charity Weeden bring their compelling experience and expertise to map out the technology, international policy, and scalability that will define the next generation of space exploration.

 

What do space and archaeology have in common? One is the future, while the other is the study of the past. However, space has a past, too. Hosts Chris Blackerby and Charity Weeden spoke with space archaeologist Alice Gorman on this exciting new field.

“It is surprising to have space and archaeology in the same sentence. It came together for me one looking at the night sky noticing the stars but also the space junk put into orbit by humans,” Gorman explained.

“There is space debris in orbit from rocket bodies.  Some should be removed, but others may have historical value.” – Alice Gorman

Before that night, she was a traditional archaeologist, but she’d also had a fascination with space since childhood. Now her two passions were one.

This revelation came 20 years ago, and she wondered if there were others with the same questions. Soon, she met two others, John Campbell and Beth Laura O’Leary. At first, the subject was thought to be irrelevant but grew to be a field with impact.

“There’s so much activity in space now, and we’re talking more about sustainability and human interaction with the environment,” Gorman said.

With the growth of the sector came the term orbital heritage. Gorman explained its meaning. “There is space debris in orbit from rocket bodies. Some are useless and come with the risk of fragmentation or collision. Some should be removed, but others may have historical value.”

Keeping some pieces in orbit is akin to the archaeological motto “leave something behind for future studies.” Gorman noted that choosing less risky pieces helps future generations learn how humans first made it to space. “It could track the evolution of change of human technology. Retrieving certain rocket pieces also provides the capacity to look at the space environment on materials.”

Listen to Previous Episodes Here!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More